109 related articles for article (PubMed ID: 30133758)
1. Heritable methylation marks associated with breast and prostate cancer risk.
Dugué PA; Dowty JG; Joo JE; Wong EM; Makalic E; Schmidt DF; English DR; Hopper JL; Pedersen J; Severi G; MacInnis RJ; Milne RL; Giles GG; Southey MC
Prostate; 2018 Sep; 78(13):962-969. PubMed ID: 30133758
[TBL] [Abstract][Full Text] [Related]
2. Genome-Wide Measures of Peripheral Blood Dna Methylation and Prostate Cancer Risk in a Prospective Nested Case-Control Study.
FitzGerald LM; Naeem H; Makalic E; Schmidt DF; Dowty JG; Joo JE; Jung CH; Bassett JK; Dugue PA; Chung J; Lonie A; Milne RL; Wong EM; Hopper JL; English DR; Severi G; Baglietto L; Pedersen J; Giles GG; Southey MC
Prostate; 2017 Apr; 77(5):471-478. PubMed ID: 28116812
[TBL] [Abstract][Full Text] [Related]
3. Heritable methylation marks associated with prostate cancer risk.
Dowty JG; Yu C; Hosseinpour M; Joo JE; Wong EM; Nguyen-Dumont T; Rosenbluh J; Giles GG; Milne RL; MacInnis RJ; Dugué PA; Southey MC
Fam Cancer; 2023 Jul; 22(3):313-317. PubMed ID: 36708485
[TBL] [Abstract][Full Text] [Related]
4. Heritable DNA methylation marks associated with susceptibility to breast cancer.
Joo JE; Dowty JG; Milne RL; Wong EM; Dugué PA; English D; Hopper JL; Goldgar DE; Giles GG; Southey MC;
Nat Commun; 2018 Feb; 9(1):867. PubMed ID: 29491469
[TBL] [Abstract][Full Text] [Related]
5. High grade prostatic intraepithelial neoplasia does not display loss of heterozygosity at the mutation locus in BRCA2 mutation carriers with aggressive prostate cancer.
Willems-Jones A; Kavanagh L; Clouston D; Bolton D; ; Fox S; Thorne H
BJU Int; 2012 Dec; 110(11 Pt C):E1181-6. PubMed ID: 23035815
[TBL] [Abstract][Full Text] [Related]
6.
Dugué PA; Yu C; McKay T; Wong EM; Joo JE; Tsimiklis H; Hammet F; Mahmoodi M; Theys D; kConFab ; Hopper JL; Giles GG; Milne RL; Steen JA; Dowty JG; Nguyen-Dumont T; Southey MC
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33802562
[No Abstract] [Full Text] [Related]
7. Prospective study of DNA methylation at LINE-1 and Alu in peripheral blood and the risk of prostate cancer.
Barry KH; Moore LE; Liao LM; Huang WY; Andreotti G; Poulin M; Berndt SI
Prostate; 2015 Nov; 75(15):1718-25. PubMed ID: 26250474
[TBL] [Abstract][Full Text] [Related]
8. Epigenome-wide methylation in DNA from peripheral blood as a marker of risk for breast cancer.
Severi G; Southey MC; English DR; Jung CH; Lonie A; McLean C; Tsimiklis H; Hopper JL; Giles GG; Baglietto L
Breast Cancer Res Treat; 2014 Dec; 148(3):665-73. PubMed ID: 25407397
[TBL] [Abstract][Full Text] [Related]
9. Blood DNA methylation and breast cancer risk: a meta-analysis of four prospective cohort studies.
Bodelon C; Ambatipudi S; Dugué PA; Johansson A; Sampson JN; Hicks B; Karlins E; Hutchinson A; Cuenin C; Chajès V; Southey MC; Romieu I; Giles GG; English D; Polidoro S; Assumma M; Baglietto L; Vineis P; Severi G; Herceg Z; Flanagan JM; Milne RL; Garcia-Closas M
Breast Cancer Res; 2019 May; 21(1):62. PubMed ID: 31101124
[TBL] [Abstract][Full Text] [Related]
10. ABO blood group alleles and prostate cancer risk: Results from the breast and prostate cancer cohort consortium (BPC3).
Markt SC; Shui IM; Unger RH; Urun Y; Berg CD; Black A; Brennan P; Bueno-de-Mesquita HB; Gapstur SM; Giovannucci E; Haiman C; Henderson B; Hoover RN; Hunter DJ; Key TJ; Khaw KT; Canzian F; Larranga N; Le Marchand L; Ma J; Naccarati A; Siddiq A; Stampfer MJ; Stattin P; Stevens VL; Stram DO; Tjønneland A; Travis RC; Trichopoulos D; Ziegler RG; Lindstrom S; Kraft P; Mucci LA; Choueiri TK; Wilson KM
Prostate; 2015 Nov; 75(15):1677-81. PubMed ID: 26268879
[TBL] [Abstract][Full Text] [Related]
11. Correlation between the germline methylation status in ERβ promoter and the risk in prostate cancer: a prospective study.
Wang L; Zhang P; Meng X; Chen X; Xiang Z; Lin X; Liu Y; Gan W; Han X; Li D
Fam Cancer; 2016 Apr; 15(2):309-15. PubMed ID: 26547439
[TBL] [Abstract][Full Text] [Related]
12. Association between methylation of SHP-1 isoform I and SSTR2A promoter regions with breast and prostate carcinoma development.
Tiscornia MM; González HS; Lorenzati MA; Zapata PD
Cancer Invest; 2015 Mar; 33(3):61-9. PubMed ID: 25635370
[TBL] [Abstract][Full Text] [Related]
13. [Genome-wide analysis of DNA methylation in prostate cancer using the technology of Infinium HumanMethylation450 BeadChip (HM450)].
Babalyan KA; Sultanov R; Generozov EV; Zakharzhevskaya NB; Sharova EI; Peshkov MN; Vasilev AO; Govorov AV; Pushkar DY; Prilepskaya EA; Danilenko SA; Babikova EA; Larin AK; Govorun VM
Vopr Onkol; 2016; 62(1):122-32. PubMed ID: 30444590
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide DNA methylation measurements in prostate tissues uncovers novel prostate cancer diagnostic biomarkers and transcription factor binding patterns.
Kirby MK; Ramaker RC; Roberts BS; Lasseigne BN; Gunther DS; Burwell TC; Davis NS; Gulzar ZG; Absher DM; Cooper SJ; Brooks JD; Myers RM
BMC Cancer; 2017 Apr; 17(1):273. PubMed ID: 28412973
[TBL] [Abstract][Full Text] [Related]
15. Germline BRCA mutations denote a clinicopathologic subset of prostate cancer.
Gallagher DJ; Gaudet MM; Pal P; Kirchhoff T; Balistreri L; Vora K; Bhatia J; Stadler Z; Fine SW; Reuter V; Zelefsky M; Morris MJ; Scher HI; Klein RJ; Norton L; Eastham JA; Scardino PT; Robson ME; Offit K
Clin Cancer Res; 2010 Apr; 16(7):2115-21. PubMed ID: 20215531
[TBL] [Abstract][Full Text] [Related]
16. RHCG and TCAF1 promoter hypermethylation predicts biochemical recurrence in prostate cancer patients treated by radical prostatectomy.
Strand SH; Switnicki M; Moller M; Haldrup C; Storebjerg TM; Hedegaard J; Nordentoft I; Hoyer S; Borre M; Pedersen JS; Wild PJ; Park JY; Orntoft TF; Sorensen KD
Oncotarget; 2017 Jan; 8(4):5774-5788. PubMed ID: 28052017
[TBL] [Abstract][Full Text] [Related]
17. Prediagnostic White Blood Cell DNA Methylation and Risk of Breast Cancer in the Prostate Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) Cohort.
Sturgeon SR; Sela DA; Browne EP; Einson J; Rani A; Halabi M; Kania T; Keezer A; Balasubramanian R; Ziegler RG; Schairer C; Kelsey KT; Arcaro KF
Cancer Epidemiol Biomarkers Prev; 2021 Aug; 30(8):1575-1581. PubMed ID: 34108140
[TBL] [Abstract][Full Text] [Related]
18. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia.
Kang GH; Lee S; Lee HJ; Hwang KS
J Pathol; 2004 Feb; 202(2):233-40. PubMed ID: 14743506
[TBL] [Abstract][Full Text] [Related]
19. Prospective study of DNA methylation at chromosome 8q24 in peripheral blood and prostate cancer risk.
Barry KH; Moore LE; Sampson JN; Koutros S; Yan L; Meyer A; Reddy M; Oler AJ; Cook MB; Fraumeni JF; Yeager M; Amundadottir LT; Berndt SI
Br J Cancer; 2017 May; 116(11):1470-1479. PubMed ID: 28463958
[TBL] [Abstract][Full Text] [Related]
20. I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma.
Jerónimo C; Varzim G; Henrique R; Oliveira J; Bento MJ; Silva C; Lopes C; Sidransky D
Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):445-50. PubMed ID: 12010858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
